House Dust Mite Allergy Global Market Report 2025

House dust mite allergy refers to an allergic reaction triggered by small insects commonly found in household dust. This encompasses the treatment methods employed to address allergic responses such as sneezing and other allergy-related conditions.

The primary product types for managing house dust mite allergy include tablets, nasal drops, and injectables. Tablets represent a compact, solid-dose form that may contain medications with or without excipients. Treatment modalities encompass medication, immunotherapy, nasal irrigation, and other approaches. Diagnosis involves methods such as the skin prick test (SPT) and specific immunoglobulin E (IgE) blood test, among others, utilizing various dosage forms such as solid and liquid. These products find application across diverse end-users, including hospitals, homecare settings, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The house dust mite allergy market research report is one of a series of new reports from The Business Research Company that provides house dust mite allergy market statistics, including house dust mite allergy industry global market size, regional shares, competitors with a house dust mite allergy market share, detailed house dust mite allergy market segments, market trends and opportunities and any further data you may need to thrive in the house dust mite allergy industry. This house dust mite allergy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The house dust mite allergy market size has grown rapidly in recent years. It will grow from $2.11 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to increased awareness and education, advancements in diagnostic tools, research and clinical studies, healthcare infrastructure development, regulatory guidelines and standards.

The house dust mite allergy market size is expected to see rapid growth in the next few years. It will grow to $4.04 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to regulatory support and allergen labeling, rising allergy prevalence, telemedicine and remote care, increased focus on precision medicine, expansion of allergen-avoidance products. Major trends in the forecast period include public health awareness campaigns, integration of digital health solutions, focus on indoor environmental quality, growth in immunotherapy solutions, advancements in allergen avoidance products.

The forecast of 14.3% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for allergen-specific IgE test strips and sublingual immunotherapy solutions, sourced from key regions such as Denmark and Sweden, which could lead to delayed allergy diagnoses and increased treatment costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of asthma is expected to drive the growth of the house dust mite allergy market in the future. Asthma is a condition that causes the airways to narrow, swell, and sometimes produce excess mucus, leading to breathing difficulties. Asthma patients are more susceptible to environmental dust, which can trigger allergic reactions and worsen their condition, resulting in a greater need for anti-allergic medications. Consequently, the rising prevalence of asthma increases the demand for treatments targeting house dust mite allergies. For example, in September 2024, the Asthma and Allergy Foundation of America, a US-based community organization, reported that approximately 10 people die from asthma each day in the U.S., accounting for 3,235 deaths in 2022. Many of these deaths could be prevented with appropriate care and treatment. Therefore, the prevalence of asthma is fueling the demand for house dust mite allergy treatments.

The rise in healthcare expenditure is expected to drive the growth of the house dust mite allergy market in the future. Increased healthcare spending enhances access to medical services, promotes advancements in diagnostic technologies, funds research and development, supports the creation of targeted therapies, expands the availability of allergy management products, improves health insurance coverage, and encourages government initiatives to tackle allergy-related issues. For example, in December 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported that U.S. healthcare spending in 2022 increased by 4.1%, reaching $4.5 trillion, exceeding the 3.2% growth seen in 2021. As a result, the growing healthcare expenditure is contributing to the expansion of the house dust mite allergy market.

The growth of the house dust mite allergy market is expected to be fueled by the increase in urbanization. Urbanization, marked by the expansion of cities and migration from rural to urban areas, creates conditions favorable for the proliferation of microscopic allergens such as dust mites. The trend of escalating urbanization, coupled with growing awareness of indoor allergens and their health impact, is projected to drive demand for diagnostic tools, treatments, and preventive measures related to house dust mite allergies. For instance, as of April 2022, more than 4.3 billion people, constituting 55% of the world's population, lived in urban settings, and this number is expected to rise to 80% by 2050, as reported by the World Economic Forum. Thus, increasing urbanization is a key factor contributing to the growth of the house dust mite allergy market.

Major companies in the house dust mite allergy market are concentrating on developing innovative solutions, such as sublingual tablets aimed at treating house dust mite allergies, to tackle the rising prevalence of these allergies. A sublingual tablet for treating house dust mite allergies is a form of immunotherapy where a tablet is placed under the tongue, allowing it to dissolve and release small doses of the allergen that triggers the allergy. For example, in January 2023, ALK-Abello A/S, a pharmaceutical company based in Denmark, received FDA approval for ODACTRA, a sublingual tablet designed for adolescents aged 12 to 17, thereby expanding its previous indication for adults. This approval meets a critical need, as nearly 50% of allergy sufferers are sensitive to house dust mites. Clinical trials showed that ODACTRA effectively alleviated allergy symptoms and had a safety profile comparable to that seen in adults. Although the treatment is generally well-tolerated, patients are advised to keep auto-injectable epinephrine available due to the risk of severe allergic reactions.

Major companies in the house dust mite allergy market are leveraging AI-powered allergy testing to gain a competitive edge. Allergy testing evaluates an individual's immune response to specific allergens. Metropolis Healthcare, in May 2023, launched a 4th generation allergy testing technology based on Component Resolved Diagnostics (CRD) and powered by artificial intelligence. This innovative testing platform assists clinicians in making informed decisions and offers insights into personalized treatment courses for allergic diseases. The technology, utilizing a Nanotechnology-based Multiplex system, enables the detection of specific IgE antibodies against 295 different allergens through a simple blood test, enhancing the precision of allergy-related diagnostic services.

Major companies operating in the house dust mite allergy market include Allergy Therapeutics Plc, Bayer AG, Catalent Inc., GSK Plc, Merz Pharma GmbH & Co KGaA, Sanofi S A, Shionogi & Co. Ltd., Stallergenes Greer International AG, Merck & Co. Inc., Torii Pharmaceutical Co. Ltd., Ergomed PLC, DMS Group, HAL Allergy Group, Trio Lifescience Private Limited, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Johnson and Johnson Inc., Circassia Pharmaceuticals Plc, Biomay Ag, GlaxoSmithKline

North America was the largest region in the house dust mite allergy market in 2024. Asia-pacific is expected to be the fastest-growing region in the house dust mite allergy market report during the forecast period. The regions covered in the house dust mite allergy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the house dust mite allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The house dust mite allergy market consists of sales of prescription drugs and over-the-counter drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

House Dust Mite Allergy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on house dust mite allergy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for house dust mite allergy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The house dust mite allergy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Nasal Drops; Injectable
• 2) By Treatment Type: Medication; Immunotherapy; Nasal Irrigation; Other Types
• 3) By Diagnosis: Skin Prick Test (SPT); Specific Immunoglobulin E (IgE) Blood Test; Other Diagnosis
• 4) By Dosage Forms: Solid; Liquid
• 5) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Tablets: Sublingual Tablets; Oral Tablets
• 2) By Nasal Drops: Antihistamine Nasal Drops; Corticosteroid Nasal Drops
• 3) By Injectable: Allergen Immunotherapy Injections; Corticosteroid Injections
• Companies Mentioned: Allergy Therapeutics Plc; Bayer AG; Catalent Inc.; GSK Plc; Merz Pharma GmbH & Co KGaA; Sanofi S A; Shionogi & Co. Ltd.; Stallergenes Greer International AG; Merck & Co. Inc.; Torii Pharmaceutical Co. Ltd.; Ergomed PLC; DMS Group; HAL Allergy Group; Trio Lifescience Private Limited; Teva Pharmaceutical Industries Ltd.; Eli Lilly and Company; Johnson and Johnson Inc.; Circassia Pharmaceuticals Plc; Biomay Ag; GlaxoSmithKline
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.